ALVO (ALVO) Stock Price & Analysis
ALVO (ALVO) fell 1.11% to USD 5.32 as of September 8, 2026 at 10:58 UTC, according to Nexqual real-time market data.
ALVO last closed at USD 5.32; the session ranged USD 5.21–5.4 on volume of 535,401 shares. Market capitalization is —, with a 52-week range of USD 2.94–9.25 (NGM). Source: Nexqual, September 8, 2026 at 10:58 UTC.
Key Statistics (as of September 8, 2026 at 10:58 UTC)
| Price | USD 5.32 |
|---|---|
| Change | ▼ 1.11% (down) |
| Previous Close | USD 5.32 |
| Open | USD 5.32 |
| Day Range | USD 5.21 – 5.4 |
| 52-Week Range | USD 2.94 – 9.25 |
| Volume | 535,401 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (ALVO)
Nexqual's technical model rates ALVO "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 10:58 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.53 (overbought) |
| vs SMA50 | Above (USD 3.93) |
| MACD | 0.43 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHC | Sotera Health Company | USD 18.9 | ▼ 0.32% |
| GBTG | Global Business Travel Group, I | USD 9.48 | ▲ 0% |
| EVO | Evotec SE | USD 1.86 | ▼ 2.11% |
| PROK | ProKidney Corp. | USD 2.01 | ▲ 5.24% |
| ROIV | Roivant Sciences Ltd. | USD 34.93 | ▲ 2.19% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:58 UTC. This page is informational and not investment advice.